First-Line Treatment Strategy for HER2-Positive Metastatic Breast Cancer

Kareen summarizes frontline regimens DHP or THP and notes emerging data on trials like Destiny Breast 09.

Play episode from 06:16

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!